Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Multi-omic approach decodes paradoxes of the triple-negative breast cancer

Lessons for predictive, preventive and personalised medicine
: Golubnitschaja, O.; Filep, N.; Yeghiazaryan, K.; Blom, H.J.; Hofmann-Apitius, M.; Kuhn, W.


Amino acids 50 (2018), No.3-4, pp.383-395
ISSN: 0939-4451 (Print)
ISSN: 1438-2199 (Online)
Journal Article
Fraunhofer SCAI ()

Breast cancer epidemic in the early twenty-first century results in around two million new cases and half-a-million of the disease-related deaths registered annually worldwide. A particularly dramatic situation is attributed to some specific patient subgroups such as the triple-negative breast cancer (TNBC). TNBC is a particularly aggressive type of breast cancer lacking clear diagnostic approach and targeted therapies. Consequently, more than 50% of the TNBC patients die of the metastatic BC within the first 6 months of the diagnosis. In the current study we have hypothesised that multi-omic approach utilising blood samples may lead to discovery of a unique molecular signature of the TNBC subtype. The results achieved demonstrate, indeed, multi-omics as highly promising approach that could be of great clinical utility for development of predictive diagnosis, targeted prevention and treatments tailored to the person—overall advancing the management of the TNBC.